High levels of amyloid-β protein from S182 (Glu246) familial Alzheimerʼs cells

Ralph N. Martins, Brian Turner, Richard T. Carroll, David Sweeney, K. S. Kim, Henryk M. Wı́sniewski, John P. Blass, Gary E. Gibson, Sam Gandy

Neuroreport · 1995 · 52 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

Most early-onset familial Alzheimer disease is associated with missense mutations in S182, a membrane protein on chromosome 14. We investigated amyloid-beta protein (A beta) precursor (A beta PP) metabolism in skin fibroblasts from S182 (Glu246)-affected individuals and unaffected family members. Steady-state A beta PP levels were similar among all lines as was the degree of increase in soluble A beta PP released upon stimulation of cells with either phorbol ester or serum. Among all lines studied, A beta levels were consistently detectable only in the medium of a single line of S182 (Glu246) cells, consistent with the conclusion that some S182 mutant lines may accumulate A beta in their conditioned media. Studies of cells from additional individuals and under other conditions will be required to establish this association of elevated A beta levels with S182 mutations.